OSSIUM HEALTH, INC.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2016-01-01
- Employees
- 51
- Market Cap
- -
- Website
- http://www.ossiumhealth.com
Clinical Trials
4
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:4
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 1
4 (100.0%)A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies
Phase 1
Recruiting
- Conditions
- Acute LeukemiaAcute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAcute Biphenotypic LeukemiaAcute Undifferentiated LeukemiaCLL (Chronic Lymphocytic Leukemia)Chronic Myeloid Leukemia (CML)MDS (Myelodysplastic Syndrome)Non-Hodgkin LymphomasHodgkins Lymphoma
- First Posted Date
- 2022-10-21
- Last Posted Date
- 2025-06-25
- Lead Sponsor
- Ossium Health, Inc.
- Target Recruit Count
- 12
- Registration Number
- NCT05589896
- Locations
- 🇺🇸
City of Hope, Duarte, California, United States
🇺🇸Moffitt Cancer Center, Tampa, Florida, United States
🇺🇸Henry Ford Cancer Institute, Detroit, Michigan, United States
Mesenchymal Stem Cells (MSCs) for Steroid Refractory Acute GVHD (SR-aGVHD)
Phase 1
Withdrawn
- Conditions
- GVHD,Acute
- First Posted Date
- 2022-07-05
- Last Posted Date
- 2022-12-23
- Lead Sponsor
- Ossium Health, Inc.
- Registration Number
- NCT05443464
Mesenchymal Stem Cells (MSCs) for Perianal Fistula
Phase 1
Withdrawn
- Conditions
- Rectal Fistula
- First Posted Date
- 2022-06-07
- Last Posted Date
- 2022-12-23
- Lead Sponsor
- Ossium Health, Inc.
- Registration Number
- NCT05407766
Cryopreserved MMUD BM With PTCy for Hematologic Malignancies
Phase 1
Withdrawn
- Conditions
- T-lymphoblastic LymphomaAcute Biphenotypic LeukemiaAcute Lymphocytic LeukemiaAcute Myeloid LeukemiaAcute LeukemiaAcute Undifferentiated LeukemiaMyelodysplastic Syndromes
- Interventions
- Radiation: Total Body IrradiationProcedure: Bone Marrow Transplant
- First Posted Date
- 2021-12-28
- Last Posted Date
- 2023-11-01
- Lead Sponsor
- Ossium Health, Inc.
- Registration Number
- NCT05170828
News
No news found